levophencynonate
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2014 (NCT02299804)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Glutamate [NMDA] receptor subunit 3AINHIBITOR
GRIN3A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- levophencynonate
- levophencynonate
- levo phencynonate hydrochloride
- levo phencynonate hydrochloride
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02241629 | Phase 2 | Aug 1, 2014 | Qingdao Municipal Hospital, Sihuan Pharmaceutical Holdings Group Ltd. |
| NCT02299804 | Phase 2 | Jan 1, 2014 | Jiao Tong University, Sihuan Pharmaceutical Holdings Group Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sihuan Pharmaceutical Holdings Group Ltd. | For profit | 2 | 2 | 1 | 2014 |
| Jiao Tong University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Qingdao Municipal Hospital | Academic/Hospital | 1 | 0 | 1 | 2014 |
3 organizations
Page 1 / 1